Back to Search
Start Over
Health Technology Assessment and Its Use in Drug Policies in China
- Source :
- Value in Health Regional Issues. 15:138-148
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
-
Abstract
- Objective To review drug policies, health technology assessment (HTA), and HTA's use in drug policies in China, to further improve the quality and efficiency of drugs. Methods This study draws on multiple methods. A systematic review of the literature, review of Chinese government documents and statistical handbooks, and authors' experiences in drug policies and HTA in China were combined to achieve the objective. Results Of 571 studies identified in the initial search, 14 eligible articles (6 English, 8 Chinese) were finally included. On the Web site of the National Health and Family Planning Commission, the National Development and Reform Commission, and the Ministry of Human Resources and Social Security, we found that HTA or pharmacoeconomics evaluation is mentioned in recent years and its frequency has been increasing; however, there was not one hit about HTA or PE on the Web site of China Food and Drug Administration. Conclusions The decision makers have realized the importance and value of HTA and have tried to integrate HTA into drug policies and regulations. However, the application of HTA findings to drug policymaking is not yet widespread and there are a number of challenges in using HTA in China. Therefore, it is necessary to establish a national HTA commission and develop pharmacoeconomics guidelines to support the use of HTA in decision making. Moreover, the most important steps are to encourage technology innovation, groom more HTA experts, and build reliable databases in China.
- Subjects :
- China
Technology Assessment, Biomedical
media_common.quotation_subject
Economics, Econometrics and Finance (miscellaneous)
Commission
03 medical and health sciences
Pharmacoeconomics
0302 clinical medicine
Humans
Quality (business)
030212 general & internal medicine
Policy Making
Human resources
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
media_common
Government
business.industry
030503 health policy & services
Health Policy
Health technology
Public relations
Social security
Drug and Narcotic Control
Health Impact Assessment
0305 other medical science
business
Subjects
Details
- ISSN :
- 22121099
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- Value in Health Regional Issues
- Accession number :
- edsair.doi.dedup.....41ba85772049d39872bc40e1140d286a